Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-

Updated on: September 28,2024

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-

Updated on:September 28,2024

A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainDrs. Akash Patel and Tiemo Klisch, investigators at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Childr

Updated on: February 19,2024

A study refines a molecular marker that accurately predicts the recurrence of aggressive meningiomas

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainDrs. Akash Patel and Tiemo Klisch, investigators at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Childr

Updated on:February 19,2024

Multi-modal AI models for intermediate- to high-risk localized prostate cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910

Updated on: January 30,2024

Multi-modal AI models for intermediate- to high-risk localized prostate cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910

Updated on:January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024

Virus linked to cancer takes over 'cellular mail' to alter tumor environment

by University of North Carolina at Chapel Hill School of MedicineRyan P. McNamara, PhD, is a postdoctoral research associate at UNC Lineberger. Credit: University of North Carolina at Chapel Hill

Updated on: May 07,2024

Virus linked to cancer takes over 'cellular mail' to alter tumor environment

by University of North Carolina at Chapel Hill School of MedicineRyan P. McNamara, PhD, is a postdoctoral research associate at UNC Lineberger. Credit: University of North Carolina at Chapel Hill

Updated on:May 07,2024

A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

by Ludwig Cancer ResearchCredit: CC0 Public DomainThe cells of a subset of myeloproliferative neoplasms (MPNs), slow-growing blood cancers, have frameshift mutations in their calreticulin (CALR)

Updated on: January 29,2024

A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

by Ludwig Cancer ResearchCredit: CC0 Public DomainThe cells of a subset of myeloproliferative neoplasms (MPNs), slow-growing blood cancers, have frameshift mutations in their calreticulin (CALR)

Updated on:January 29,2024

Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainCertain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated wit

Updated on: April 28,2024

Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainCertain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated wit

Updated on:April 28,2024

ASCO: Low-fat dietary pattern cuts breast cancer deaths

(HealthDay)—A low-fat dietary intervention is associated with reductions in deaths after breast cancer and deaths from breast cancer among postmenopausal women after long-term follow-up, according to

Updated on: March 30,2024

ASCO: Low-fat dietary pattern cuts breast cancer deaths

(HealthDay)—A low-fat dietary intervention is associated with reductions in deaths after breast cancer and deaths from breast cancer among postmenopausal women after long-term follow-up, according to

Updated on:March 30,2024

Boosting the effects of a particular microRNA may benefit patients with cervical cancer

by WileyHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cancer

Updated on: February 18,2024

Boosting the effects of a particular microRNA may benefit patients with cervical cancer

by WileyHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cancer

Updated on:February 18,2024

Researcher explores new treatment for advanced biliary tract cancers

by Blair Willis,University of ArizonaCredit: CC0 Public DomainA new treatment that may extend survival for patients with advanced biliary tract cancers—who typically face a grim outlook with ave

Updated on: June 06,2024

Researcher explores new treatment for advanced biliary tract cancers

by Blair Willis,University of ArizonaCredit: CC0 Public DomainA new treatment that may extend survival for patients with advanced biliary tract cancers—who typically face a grim outlook with ave

Updated on:June 06,2024

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in

Updated on: January 30,2024

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in

Updated on:January 30,2024

Age, cancer type affect COVID-19 vaccine uptake in cancer patients

by Elana GotkineFor patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 inCance

Updated on: January 02,2024

Age, cancer type affect COVID-19 vaccine uptake in cancer patients

by Elana GotkineFor patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 inCance

Updated on:January 02,2024